doi: 10.1177/1352458509104590.
25. Sheikh AM, Nagai A, Wakabayashi K, et al. Mesenchymal stem cell
transplantation modulates neuroinflammation in focal cerebral ischemia:
contribution of fractalkine and IL-5. Neurobiol Dis. 2011; 41(3): 717-724. doi:
10.1016/j.nbd.2010.12.009.
26. Sun L, Wang D, Liang J, et al. Umbilical cord mesenchymal stem cell
transplantation in severe and refractory systemic lupus erythematosus. Arthritis
Rheum. 2010; 62(8): 2467-75. doi: 10.1002/art.27548.
27. Xu J, Wang D, Liu D, et al. Allogeneic mesenchymal stem cell treatment
alleviates experimental and clinical Sjögren syndrome. Blood. 2012; 120(15):
3142-51. doi: 10.1182/blood-2011-11-391144.
28. Gesundheit B, Ashwood P, Keating A, Naor D, Melamed M,
Rosenzweig JP. Therapeutic properties of mesenchymal stem cells for autism
spectrum disorders. Med Hypotheses. 2015; 84(3): 169-77. doi:
10.1016/j.mehy.2014.12.016.
29. Lalu MM, McIntyre L, Pugliese C, et al. Safety of cell therapy with
mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of
clinical
trials.
PLoS
One.
2012;
7(10):
e47559.
doi:
10.1371/journal.pone.0047559.
30. Lv YT, Zhang Y, Liu M, et al. Transplantation of human cord blood
mononuclear cells and umbilical cord-derived mesenchymal stem cells in autism.
J Transl Med. 2013; 11: 196. doi: 10.1186/1479-5876-11-196.
31. Sharma A, Gokulchandran N, Sane H, et al. Autologous bone marrow
mononuclear cell therapy for autism: an open label proof of concept study. Stem
Cells Int. 2013; 2013: 623875. doi: 10.1155/2013/623875.
32. Hospital Universitario; Jose Gonzalez. autologous bone marrow stem
cells for children with autism spectrum disorders. In: ClinicalTrials.gov
[Internet]. Bethesda (MD): National Library of Medicine (US). 2000- [cited 2016
July]. Available from: https://clinicaltrials.gov/ct2/show/NCT01740869 NLM
Identifier: NCT01740869.
